# Allocure

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/allocure

- Industry: Biotechnology
- Headquarters: Burlington, US
- Website: www.allocure.com
- Total disclosed funding: $40M
- Latest round: Series B (Apr 2, 2012)
- Investors on record: 4

## About

AlloCure is a biotechnology company, develops cell therapies for the treatment of various kidney diseases, organ transplants, and multi-organ injuries.

## Funding rounds

- Series B, Apr 2, 2012, $25M — SV Health Investors, Novo Holdings, Lundbeckfond Ventures
- Series A, Jul 2, 2008, $15M — SV Health Investors, Novo Holdings A/S

## Investors

- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series A, Series B
- Novo Holdings A/S — Series A
- Novo Holdings — Series B
- Lundbeckfond Ventures (https://capitalatlas.ai/funds/lundbeckfond-ventures) — Series B